CURRENT CLINICAL TRIALS IN CALIFORNIA RECRUITING FOR SCLERODERMA:
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (BLISSc-ILD)
Sponsor: GlaxoSmithKline
We are part of an inspiring community.
Together, we can accomplish so much more.
Join us and support our mission.
Contact us to find out more about volunteer opportunities, fundraising events,
and ways that you can help us get our message to your friends and family.
Sign up to to receive our Foundation updates for news, patient education, and events.
Email: info@myscleroderma.org
